About Ispire Technology Inc. - Common Stock (ISPR)
Ispire Technology Inc. is a company specializing in innovative solutions for the cannabis industry, focusing primarily on the development and distribution of advanced vaping products and devices. The company aims to enhance the consumer experience by integrating cutting-edge technology and high-quality materials into its product offerings. Ispire is committed to establishing a strong presence in the market through its dedication to product safety, efficiency, and user satisfaction, catering to an expanding audience of cannabis consumers looking for reliable and enjoyable methods of consumption. Read More
Ispire Technology (NASDAQ:ISPR) said it is entering fiscal 2027 with higher quarterly revenue, a reduced operating cost base and new manufacturing licenses in Malaysia, while continuing to work through legacy receivables and pursue commercialization opportunities for its nicotine technology platform
LOS ANGELES, CA / ACCESS Newswire / September 9, 2026 / Ispire Technology Inc. (Nasdaq:ISPR) ("Ispire," the "Company," "we," "us," or "our"), an innovator in vaping technology and precision dosing, announced today that it will host its earnings conference call at 8 am ET on Wednesday, September 16, 2026, to discuss the Company's financial results for its fiscal fourth quarter and full year ended June 30, 2026.
Join Women Grow Leadership Summit 2025 for 2 days of networking, advocacy and business opportunities in cannabis ft. Brittney Griner, Ricky Williams, etc.
Key Takeaways: RLX’s third quarter revenue rose 52%, as its gross margin rose more than 3 percentage points to 27.2% following a regulatory crackdown in 2021 A year after expanding beyond its China base, international business accounted for more than half of the vaping company’s revenues in the third quarter
Ispire Technology Inc. (NASDAQ: ISPR), a company with a focus on innovations in vaping technology and precision dosing, reported on Monday first quarter 2025 results for the period ended on Sept. 30, 2024. Revenue totaled $39.3 million, representing a decrease of 8.2% year-over-year to $42.9 million due to lower U.S. product sales (by $8.1 million year-over-year), partially offset by growth in Europe and other regions (notably South Africa). Gross profit increased by 13.2% to $7.7 million from $6.8 million, with gross margin improving to 19.5% from 16%, driven by a shift toward higher-margin products. Net loss amounted to $5.6 million ($0.10 per share), compared to a net loss of $1.3 million ($0.02 per share) in the prior year's period.
